- News & Analysis
Page 776
23andMe accumulates $79m in series E
The Google and Johnson & Johnson-backed genomic testing service is seeking $150m in a series E round that follows its establishment of a therapeutics group.
Jul 7, 2015GNA processes $6.6m in series B
The diagnostic technology developer will use the funds secured in the Robert Bosch-led round to bring its laser-based lead product to market.
Jul 7, 2015No tears at Oculeve with $125m exit
Stanford life sciences firm Oculeve receives $125m upfront from Allergan for its dry eye device.
Jul 7, 2015Sapvax searches for anti-cancer investors
Auckland spinout Sapvax, which is developing anti-cancer vaccines using immunotherapy technology, is searching for $8m to advance its development.
Jul 7, 2015GNA processes $6.6m in series B
The diagnostic technology developer will use the funds secured in the Robert Bosch-led round to bring its laser-based lead product to market.
Jul 6, 2015Haisco helps guide $12.5m to MST
Medical Surgery Technologies has developed a medical device that enables minimally invasive surgery with little user interaction.
Jul 6, 2015About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin